The immunologic response to infection with respiratory syncytial virus in infants.
about
Double-stranded RNA-activated protein kinase regulates early innate immune responses during respiratory syncytial virus infectionRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Viral infection of the lung: host response and sequelaeRespiratory syncytial virus infection: immune response, immunopathogenesis, and treatmentIntranasal antibody prophylaxis for protection against viral disease.Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice.CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.Respiratory syncytial virus infections in infants affected by primary immunodeficiency.Secretory immunological response in infants and children to parainfluenza virus types 1 and 2Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.Respiratory syncytial virus vaccinesCell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection.Immunity to RSV in Early-Life.Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection.Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response.Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in miceThe cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young childrenDevelopment of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus.The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and diseaseInfectivity of respiratory syncytial virus by various routes of inoculation.Ontogenesis of the formation of secretory antibodies to respiratory syncytial (RS) virusDetection, pathogenesis, and therapy of respiratory syncytial virus infectionsIdentifying infections with respiratory syncytial virus by using specific immunoglobulin G (IgG) and IgA enzyme-linked immunosorbent assays with oral-fluid samples.Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus.Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infectionThe immune response to respiratory syncytial virus infection: friend or foe?Antibody response to respiratory syncytial virus infection in children <18 months oldAnalysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection.Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples.Cryopreservation of virus-infected cells for use in the fluorescent antibody to membrane antigen test.Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus.Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host.Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections.Immunity to human and bovine respiratory syncytial virus.Respiratory syncytial virus. Brief review.Enzyme analysis for the diagnosis of infectious diseases.Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies.
P2860
Q28509475-135B0A06-12B9-4FE1-8890-A3C60B7B044EQ30240274-6FB722A2-47E6-4507-8286-6706C06E86A3Q30409296-BCC092BB-5B02-4F2D-87FE-654E941B5FE9Q33588916-1F39CE20-0445-49A9-992D-AF012DE030A4Q33683058-91C7E18E-23FB-4DCF-BAF5-EA3C9046A348Q33782181-FDE93590-B5DC-4842-9E84-A4187F3D80D9Q33801890-B0544CC5-4C03-4088-9C09-A64216CDEE10Q33892605-90701CE0-AA9F-4954-ADEA-8A7B7E722961Q33908495-A9F01AC6-D47F-46A2-B434-6512A6660A55Q33912830-C6B825D7-E4AA-48FB-A020-A323736E011EQ33975330-357BEA10-402F-4246-A2D9-8078C5B62097Q34078039-7523F35A-88EA-4F93-B242-027D4DF4C418Q34264615-0AC330B4-F3C4-45E2-8C70-CC7BAD5AAAA7Q34307704-84A50513-F3F4-410B-9CF3-A7D41EAC9C90Q35070880-A6F69C89-5FCB-4012-B1F5-A3A76B913750Q35217016-2684FE4B-84E8-489F-8B4C-054141435961Q35823116-D719C884-2C75-401C-B718-8724A1800646Q36190502-994E0F2B-2E41-4BAD-BBFA-2A802C994AB0Q36330853-81B4657E-5E45-4975-8B5F-6A57D5E755EFQ36347623-29329222-B35A-4FC5-994E-72D087D145E8Q36427297-6F24E4AD-8085-44DD-9AA1-E08981076C29Q36473082-A6DF3932-6D42-4028-94C7-8D7028D84850Q36632499-FF3274D5-3E17-4DFB-BF18-098B1301807DQ36673041-2FFE01C7-9025-4888-9EFC-6374258B504BQ36679855-84CBE5DA-F9ED-43C0-9A74-C993D8910290Q36930001-D3A3043E-046E-476B-9524-2999B6F5C077Q36994294-E1053A30-4321-4022-9A2C-AC48E7FC4A08Q37135395-D33FCC45-6611-4205-91AA-33BB22B4AC81Q37138345-48B934D5-7675-4374-A569-3FD7B0F063FBQ37205945-D96C7F6B-805C-4237-9347-AE8F33531A02Q37212728-B1D0922A-F52C-4865-9497-6D2B8F967644Q37296500-3397C270-CF65-44B1-A754-E77578A2E2E0Q37325673-CA0FAA0C-5A9E-41AE-9FE1-29C956B2C55CQ37336116-284182F6-027F-492B-8D8E-2A7F0B227276Q37712832-F107FDA0-E953-493F-AC34-AC4A2E2D8DD0Q37822410-C52A46EF-7225-4588-96FA-A509EC7DAC86Q37940915-86C1C633-33FD-4B91-9E70-FB50502CBD33Q39817548-23744738-E774-45DB-947C-7BABAE12E4E6Q40181711-92184A99-3CF8-4A11-95E5-67DFE63D3CECQ40207936-705871A1-CEB1-410C-B532-D33522B1E62D
P2860
The immunologic response to infection with respiratory syncytial virus in infants.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
The immunologic response to infection with respiratory syncytial virus in infants.
@en
type
label
The immunologic response to infection with respiratory syncytial virus in infants.
@en
prefLabel
The immunologic response to infection with respiratory syncytial virus in infants.
@en
P2093
P356
P1476
The immunologic response to infection with respiratory syncytial virus in infants.
@en
P2093
P356
10.1093/INFDIS/138.1.24
P407
P577
1978-07-01T00:00:00Z